A new study shows that Tirzepatide, marketed as Mounjaro and Zepbound, activated calorie-burning brown fat in obese mice. This discovery could explain the drug's effectiveness beyond just appetite suppression and inspire more targeted treatments for obesity and diabetes.
מקור: Latest Science News — ScienceDaily — לכתבה המלאה
כתיבת תגובה